SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912057-00-037504
Filing Date
2000-08-14
Accepted
2000-08-14 00:00:00
Documents
10
Period of Report
2000-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a10-q.txt 10-Q 120661
2 EXHIBIT 10.1 ex-10_1.txt EX-10.1 7125
3 EXHIBIT 10.2 ex-10_2.txt EX-10.2 21524
4 EXHIBIT 10.3 ex-10_3.txt EX-10.3 8779
5 EXHIBIT 10.4 ex-10_4.txt EX-10.4 21488
6 EXHIBIT 10.5 ex-10_5.txt EX-10.5 9552
7 EXHIBIT 10.6 ex-10_6.txt EX-10.6 11393
8 EXHIBIT 10.7 ex-10_7.txt EX-10.7 21500
9 EXHIBIT 10.8 ex-10_8.txt EX-10.8 21517
10 EXHIBIT 27 ex-27.txt EX-27 2048
  Complete submission text file 0000912057-00-037504.txt   248256
Mailing Address 236 WEST CUMMINGS PARK WOBURN MA 01801
Business Address 236 WEST CUMMINGS PARK WOBURN MA 01801 6179326616
ANIKA THERAPEUTICS INC (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 700781
SIC: 2836 Biological Products, (No Diagnostic Substances)